Clinical utility of endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling of pancreatic cancer
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Endoscopic ultrasound-guided tissue acquisition (EUS-TA) is essential for the diagnosis of pancreatic cancer. The feasibility of comprehensive genomic profiling (CGP) using samples obtained by EUS-TA has been under recent discussion. This study aimed to evaluate the utility of EUS-TA for CGP in a clinical setting. Methods: CGP was attempted in 178 samples obtained from 151 consecutive patients with pancreatic cancer at the Aichi Cancer Center between October 2019 and September 2021. We evaluated the adequacy of the samples for CGP and determined the factors associated with the adequacy of the samples obtained by EUS-TA retrospectively. Results: The overall adequacy for CGP was 65.2% (116/178), which was significantly different among the four sampling methods (EUS-TA vs. surgical specimen vs. percutaneous biopsy vs. duodenal biopsy, 56.0% [61/109] vs. 80.4% [41/51] vs. 76.5% [13/17] vs. 100.0% [1/1], respectively; p=0.022). In a univariate analysis, needle gauge/type was associated with adequacy (22 G fine-needle aspiration vs. 22 G fine-needle biopsy [FNB] vs. 19 G-FNB, 33.3% (5/15) vs. 53.5% (23/43) vs. 72.5% (29/40); p=0.022). The sample adequacy of 19 G-FNB for CGP was 72.5% (29/40), and there was no significant difference between 19 G-FNB and surgical specimens (p=0.375). Conclusions: To obtain adequate samples for CGP with EUS-TA, 19 G-FNB was shown to be the best in clinical practice. However, 19 G-FNB was not still sufficient, so further efforts are required to improve adequacy for CGP.
Abstract
Background/Aims: Endoscopic ultrasound-guided tissue acquisition (EUS-TA) is essential for the diagnosis of pancreatic cancer. The feasibility of comprehensive genomic profiling (CGP) using samples obtained by EUS-TA has been under recent discussion. This study aimed to evaluate the utility of EUS-TA for CGP in a clinical setting. Methods: CGP was attempted in 178 samples obtained from 151 consecutive patients with pancreatic cancer at the Aichi Cancer Center between October 2019 and September 2021. We evaluated the adequacy of the samples for CGP and determined the factors associated with the adequacy of the samples obtained by EUS-TA retrospectively. Results: The overall adequacy for CGP was 65.2% (116/178), which was significantly different among the four sampling methods (EUS-TA vs. surgical specimen vs. percutaneous biopsy vs. duodenal biopsy, 56.0% [61/109] vs. 80.4% [41/51] vs. 76.5% [13/17] vs. 100.0% [1/1], respectively; p=0.022). In a univariate analysis, needle gauge/type was associated with adequacy (22 G fine-needle aspiration vs. 22 G fine-needle biopsy [FNB] vs. 19 G-FNB, 33.3% (5/15) vs. 53.5% (23/43) vs. 72.5% (29/40); p=0.022). The sample adequacy of 19 G-FNB for CGP was 72.5% (29/40), and there was no significant difference between 19 G-FNB and surgical specimens (p=0.375). Conclusions: To obtain adequate samples for CGP with EUS-TA, 19 G-FNB was shown to be the best in clinical practice. However, 19 G-FNB was not still sufficient, so further efforts are required to improve adequacy for CGP.
참고문헌 (25)
- Park DH, "Feasibility and safety of a novel dedicated device for one-step EUS-guided biliary drainage : a randomized trial", J Gastroenterol Hepatol, 30, pp.1461~1466 (2015)
- Siegel RL, "Cancer statistics, 2019", CA Cancer J Clin, 69, pp.7~34 (2019)
- Sunami K, "Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting : a hospital-based study", Cancer Sci, 110, pp.1480~1490 (2019)
- Ebi H, "Precision oncology and the universal health coverage system in Japan", JCO Precis Oncol, 3 (2019)
- Haba S, "Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions : Japanese large single center experience", J Gastroenterol, 48, pp.973~981 (2013)
- Elhanafi S, "Comparison of endoscopic ultrasound tissue acquisition methods for genomic analysis of pancreatic cancer", J Gastroenterol Hepatol, 34, pp.907~913 (2019)
- Takano S, "Clinical significance of genetic alterations in endoscopically obtained pancreatic cancer specimens", Cancer Med, 10, pp.1264~1274 (2021)
- Kandel P, "Comparison of endoscopic ultrasound-guided fine-needle biopsy versus fine-needle aspiration for genomic profiling and DNA yield in pancreatic cancer : a randomized crossover trial", Endoscopy, 53, pp.376~382 (2021)
- Lee KY, "Efficacy of 3 fine-needle biopsy techniques for suspected pancreatic malignancies in the absence of an on-site cytopathologist", Gastrointest Endosc, 89, pp.825~831 (2019)
- Cotton PB, "A lexicon for endoscopic adverse events : report of an ASGE workshop", Gastrointest Endosc, 71, pp.446~454 (2010)
- "FoundationOne CDx. Specimen instructions" (2021)[URL]
- Yatabe Y, "Multiplex gene-panel testing for lung cancer patients", Pathol Int, 70, pp.921~931 (2020)
- Jones S, "Core signaling pathways in human pancreatic cancers revealed by global genomic analyses", Science, 321, pp.1801~1806 (2008)
- Waddell N, "Whole genomes redefine the mutational landscape of pancreatic cancer", Nature, 518, pp.495~501 (2015)
- Collisson EA, "Molecular subtypes of pancreatic cancer", Nat Rev Gastroenterol Hepatol, 16, pp.207~220 (2019)
- Song TJ, "The prospective randomized, controlled trial of endoscopic ultrasound-guided fine-needle aspiration using 22G and 19G aspiration needles for solid pancreatic or peripancreatic masses", Am J Gastroenterol, 105, pp.1739~1745 (2010)
- Polkowski M, "Learning, techniques, and complications of endoscopic ultrasound(EUS)-guided sampling in gastroenterology : European Society of Gastrointestinal Endoscopy(ESGE)technical guideline", Endoscopy, 44, pp.190~206 (2012)
- Khan MA, "A meta-analysis of endoscopic ultrasound-fine-needle aspiration compared to endoscopic ultrasound-fine-needle biopsy : diagnostic yield and the value of onsite cytopathological assessment", Endosc Int Open, 5, pp.E363~ (2017)
- Chhoda A, "EUS-guided needle biopsy for autoimmune pancreatitis", Clin J Gastroenterol, 13, pp.669~677 (2020)
- de Moura DT, "EUS-guided fine-needle biopsy sampling versus FNA in the diagnosis of subepithelial lesions : a large multicenter study", Gastrointest Endosc, 92, pp.108~119 (2020)
- Oppong KW, "Fork-tip needle biopsy versus fine-needle aspiration in endoscopic ultrasound-guided sampling of solid pancreatic masses : a randomized crossover study", Endoscopy, 52, pp.454~461 (2020)
- Karsenti D, "22G Acquire vs. 20G Procore needle for endoscopic ultrasound-guided biopsy of pancreatic masses : a randomized study comparing histologic sample quantity and diagnostic accuracy", Endoscopy, 52, pp.747~753 (2020)
- Sugimoto M, "Efficacy of EUS-guided FNB using a Franseen needle for tissue acquisition and microsatellite instability evaluation in unresectable pancreatic lesions", BMC Cancer, 20, pp.1094~ (2020)
- Jae Keun Park, "Factors of Endoscopic Ultrasound-Guided Tissue Acquisition for Successful Next-Generation Sequencing in Pancreatic Ductal Adenocarcinoma", Gut and Liver, 14(3), pp.387~394 (2020), 거트앤리버 소화기연관학회협의회[DOI]
- Larson BK, "Utility of endoscopic ultrasound-guided biopsy for next-generation sequencing of pancreatic exocrine malignancies", Pancreas, 47, pp.990~995 (2018)